CLINICAL_TRIALS
trial_result
· 2016-02-08
Clinical Trial Update: Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients [Phase 2]
Summary
Phase 2 trial comparing efficacy and safety of Albuterol Spiromax versus ProAir HFA in pediatric asthma patients has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2016-02-08